Advertisement

Topics

Angle’s ovarian cancer test could beat current standard

07:17 EDT 5 Jul 2017 | PharmaTimes

UK liquid biopsy group Angle has released trial findings that indicate its Parsortix blood test has the potential to out-perform the current standard of care in detecting ovarian cancer.

Original Article: Angle’s ovarian cancer test could beat current standard

NEXT ARTICLE

More From BioPortfolio on "Angle’s ovarian cancer test could beat current standard"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Ovarian Cancer
Ovarian Cancer is cancer that starts in the female reproductive organs, the ovaries. It is the fifth most common cancer among women.  Women at risk of Ovarian Cancer are those who have had few children (or had children at an older age), carriers o...